S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Corcept Therapeutics (CORT) SEC Filings & 10K Form

$22.66
-0.34 (-1.48%)
(As of 04/18/2024 ET)

Recent Corcept Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2024
3:44 PM
Corcept Therapeutics (Filer)
Form ARS
04/17/2024
5:05 AM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
6:00 PM
Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:43 PM
Corcept Therapeutics (Filer)
Form DEF 14A
04/08/2024
5:16 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
11:40 AM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
7:00 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:38 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
9:03 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
1:12 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
1:32 PM
Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SC 13G/A
03/27/2024
12:01 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
4:09 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:14 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:19 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:02 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:03 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:09 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:41 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:24 PM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:11 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
7:06 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
11:12 AM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:17 PM
Corcept Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
2:45 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:23 PM
BAKER G LEONARD JR (Filed by)
Corcept Therapeutics (Subject)
Form SC 13G/A
02/13/2024
7:47 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:25 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:59 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:08 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
7:20 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:38 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:40 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
9:04 AM
Corcept Therapeutics (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/12/2024
7:12 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/12/2024
6:51 PM
BELANOFF JOSEPH K (Filed by)
Corcept Therapeutics (Subject)
Form SC 13G/A
02/02/2024
4:39 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
1:17 PM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
7:06 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:06 AM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
6:14 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
01/02/2024
10:24 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
7:06 AM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
6:29 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
11:09 AM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
5:21 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
8:31 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
7:46 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:34 PM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
7:56 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
2:02 PM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2023
5:56 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:58 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:59 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
6:00 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:53 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:54 PM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2023
5:23 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
11:08 AM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
9:27 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2023
6:55 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
5:49 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
5:32 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
5:14 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
10:55 AM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2023
10:29 AM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2023
10:21 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/12/2023
7:19 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:36 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:26 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
3:19 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
12:50 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
11:59 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
12:17 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
5:06 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
5:07 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
2:19 PM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2023
10:27 AM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
5:12 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:04 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:41 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:06 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:15 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
5:21 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:55 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
9:07 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
1:37 PM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
12:16 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/31/2023
5:03 PM
Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
5:24 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
3:53 PM
Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
08/15/2023
4:35 PM
Corcept Therapeutics (Subject)
MAHONEY DAVID L (Reporting)
Form 144/A
08/14/2023
4:26 PM
Corcept Therapeutics (Subject)
Hunt Hazel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
1:09 PM
Corcept Therapeutics (Subject)
MAHONEY DAVID L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:15 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
4:20 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:04 PM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
3:30 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
4:58 PM
BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
5:10 AM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CORT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners